- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Directors of Medicamen Biotech Limited has approved the allotment of 8,48,220 equity shares at an issue price of ₹530 each, totaling ₹44.96 crore, to non-promoter entities. Additionally, they approved the allotment of up to 6,50,000 fully convertible warrants, also at ₹530 each, amounting to ₹34.45 crore, to both promoter and non-promoter categories. Following these allotments, the paid-up equity share capital will increase to ₹13.56 crore.